GenScript USA Inc/ProBio Inc. Interview Guide

GenScript USA Inc/ProBio Inc. is a pioneering force in the biotechnology sector, established in 2002 and publicly traded on the Hong Kong Stock Exchange. With a robust global footprint in North America, Europe, Greater China, and Asia Pacific, GenScript excels in gene synthesis technology and operates through four key business areas: Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, and cell therapy. The company is committed to improving human and environmental health through innovative biotechnological solutions, striving to be the most dependable biotech partner worldwide. Its subsidiary, ProBio, complements these efforts by offering extensive CDMO services in cell and gene therapy, vaccine development, and biologics, facilitating a seamless transition from drug discovery to commercialization with a focus on efficiency and innovation.